UM
(Note: the search results are based on claimed items)

Browse/Search Results:  1-2 of 2 Help

Filters        
Selected(0)Clear Items/Page:    Sort:
Substantial protection against MPTP-associated Parkinson's neurotoxicity in vitro and in vivo by anti-cancer agent SU4312 via activation of MEF2D and inhibition of MAO-B Journal article
NEUROPHARMACOLOGY, 2017,Volume: 126,Page: 12-24
Authors:  Guo, Baojian;  Hu, Shengquan;  Zheng, Chengyou;  Wang, Hongyu;  Luo, Fangcheng;  Li, Haitao;  Cui, Wei;  Yang, Xifei;  Cui, Guozhen;  Mak, Shinghung;  Choi, Tony Chung-Lit;  Ma, Edmond Dik-Lung;  Wang, Yuqiang;  Lee, Simon Ming Yuen;  Zhang, Zaijun;  Han, Yifan
View | Adobe PDF | Favorite |  | TC[WOS]:15 TC[Scopus]:16 | Submit date:2018/10/31
Parkinson's disease  SU4312  Neuroprotection  Myocyte enhancer factor 2D  Monoamine oxidase-B  
New perspective on the dual functions of indirubins in cancer therapy and neuroprotection Journal article
Anti-Cancer Agents in Medicinal Chemistry, 2014,Volume: 14,Issue: 9,Page: 1213-1219
Authors:  Wang Y.;  Hoi P.M.;  Chan J.Y.-W.;  Lee S.M.-Y.
Favorite |  | TC[WOS]:11 TC[Scopus]:11 | Submit date:2018/11/06
Cancer  Cdks  Dual Function  Gsk-3  Indirubin  Neurodegeneration